Product Reports Resources Pricing Login Book a demo

Abridge

Health Tech & Medtech · Pittsburgh, United States · Founded 2018

Machine learning technology that powers ability to highlight key points and integrate insights that help people understand their care

Investors

38 investors on Abridge's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 5 investors entered at this stage
Angel Investors Network
EMC
Venrock
Bessemer Venture Partners
KdT Ventures
Series A 12 investors entered at this stage
Union Square Ventures
Yoshua Bengio
Aneesh Chopra
Esther Dyson
The University of Pittsburgh Medical Center
UPMC Enterprises
Whistler Capital Partners
IKS Health
Wittington Ventures
Pillar VC
Zen Chu
Pillar Ventures
Series B+ 21 investors entered at this stage
Andreessen Horowitz
Kaiser Permanente Ventures
UC Investments
CVS Health Ventures
SV Angel
K-ventures
Khosla Ventures
Spark Capital
CapitalG
LifePoint Health
NVentures
California HealthCare Foundation
American College of Cardiology
Redpoint
Elad Gil
Eli Lilly
IVP
Mayo Clinic
Lightspeed Venture Partners
Mass General Brigham Ventures
SCAN Group

Ownership

Who owns Abridge

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

22.5% Founders
  • Bessemer Venture Partners 14.5%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Abridge has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States97.1%
🇨🇦 Canada2.3%
🇧🇷 Brazil0.4%
3 countries shown
Web traffic by country
300K monthly visits
across markets
🇺🇸 United States77.9%
🇮🇳 India5.2%
🇳🇬 Nigeria1.5%
🇨🇦 Canada1.1%
🇦🇺 Australia1.1%
Top 5 markets shown

Talent graph

The shape of Abridge's talent

Dealroom maps Abridge's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

26 standout operatorsDealroom-flagged across the org
20 AI specialistsincl. 17 core researchers
643 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Abridge's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$12k patent portfolio · 3 active families

Estimated portfolio value
$12k
<0.01% of valuation · 6426.3× smaller than top peer Dental Monitoring ($75M)
3 active patent families

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Abridge

An AI-synthesized read of the highest-engagement posts about Abridge on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Abridge on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.